2017
DOI: 10.1542/hpeds.2017-0101
|View full text |Cite
|
Sign up to set email alerts
|

The Disputed Champion: Ampicillin and Gentamicin for Febrile Young Infants

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

1
3
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
4
2

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(4 citation statements)
references
References 25 publications
1
3
0
Order By: Relevance
“…52 Although resistance to third-generation cephalosporins was more common in children with complex chronic conditions, two-thirds of infants with a cephalosporin-resistant pathogen did not have a complex chronic condition. Therefore, our findings support the empiric use of ampicillin plus gentamicin for most infants with suspected bacteremia while awaiting bacterial culture results, particularly given the lower risk of toxicity with once daily dosing 49 and the association of third-generation cephalosporin use with development of resistant bacteria. 53 When a pathogen is identified, which frequently occurs within 24 hours, 23 the antimicrobial regimen can be adjusted to provide definitive therapy.…”
Section: Discussionsupporting
confidence: 69%
See 1 more Smart Citation
“…52 Although resistance to third-generation cephalosporins was more common in children with complex chronic conditions, two-thirds of infants with a cephalosporin-resistant pathogen did not have a complex chronic condition. Therefore, our findings support the empiric use of ampicillin plus gentamicin for most infants with suspected bacteremia while awaiting bacterial culture results, particularly given the lower risk of toxicity with once daily dosing 49 and the association of third-generation cephalosporin use with development of resistant bacteria. 53 When a pathogen is identified, which frequently occurs within 24 hours, 23 the antimicrobial regimen can be adjusted to provide definitive therapy.…”
Section: Discussionsupporting
confidence: 69%
“…Ampicillin plus gentamicin has traditionally been used for the empiric treatment of IBI in young infants. 48 However, concerns about gentamicin toxicity, 49 sub-optimal therapy with gentamicin alone in the setting of an ampicillin-resistant pathogen (up to 35% of isolates in this population), 15,19,39,44 and the low prevalence of Listeria monocytogenes 14,50,51 have all contributed to the common use of third-generation cephalosporins as empiric antimicrobial therapy for young infants, particularly in the second month of life. 9 However, we found that 11% of isolates, including those from infants in the second month of life, were resistant to third-generation cephalosoporins.…”
Section: Discussionmentioning
confidence: 99%
“…Out of the commonly employed antibiotics regimen, the combination of ampicillin with gentamicin had the highest treatment success rate at 77%, surpassing the combination of cefazolin with gentamicin, which achieved a success rate of only 60%. Therefore, the combination of ampicillin and gentamicin could be recommended as a promising choice for antibiotics therapy in jaundiced infants with UTI, which aligns with current recommendation regarding antibiotics therapy for neonatal UTI and febrile young infant in general (25). However, clinician should also take into consideration local surveillance of pathogens and antibiotics susceptibility patterns when choosing appropriate initial antibiotics treatment.…”
Section: Discussionmentioning
confidence: 67%
“…Greenhow and Cantey also concluded that for empiric use in most infants with suspected bacteremia, ampicillin plus gentamicin was an effective combination while awaiting results of bacterial culture. This combination has a lower risk of toxicity with once-daily dosing [24]. Pokhrel et al recommend a combination of piperacillin-tazobactam and ofloxacin as the first-line therapy and a combination of vancomycin and meropenem as the second-line empirical therapy in infants admitted with sepsis in a neonatal intensive care unit [25].…”
Section: Bacteriological and Antibiotic Profilementioning
confidence: 99%